pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcer: A Phase II, Double-Blind, Randomized Placebo-Controlled Trial

Gu, YQ; Cui, SJ; Liu, CJ; Zhao, JC; Li, M; Li, YQ; Yang, XL; Lv, BN; Li, MZ; Zhao, WG; Guo, W; Huang, JH; Huang, W; Qiu, ZM; Zhao, J; Yin, P; Qin, TT; Zhu, D; Sun, WJ; Ren, KY; Lu, YX; Cheng, XC; Du, L; Xiao, FJ; Zhang, QL; Wu, ZZ

Gu, YQ (corresponding author), Capital Med Univ, Xuan Wu Hosp, Vasc Surg Dept, 45 Changchun St, Beijing, Peoples R China.; Zhang, QL (corresponding author), Beijing Inst Radiat Med, Dept Expt Hematol & Biochem, 27 Taiping Rd, Beijing, Peoples R China.

HUMAN GENE THERAPY, 2021; 32 (15-16): 839

Abstract

This phase II clinical trial investigated the efficacy and safety of intramuscular injection of plasmid pUDK-HGF, which encodes the human hepatocyte g......

Full Text Link